Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
MASLD and MASH can lead to liver fibrosis, cirrhosis and liver cancer.
An increase in fatty liver disease could double liver cancer cases and nearly triple the need for transplants by 2050.
Name change emphasizes the role of metabolic dysfunction in fatty liver disease.
People with type 2 diabetes also had a fivefold higher risk for liver cancer.
Immune dysfunction due to fatty liver disease may increase susceptibility to infections.
NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.
For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.
Advanced fatty liver disease led to a greater need for medical care and more difficulty with daily activities.
In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.